India's economic engine is revving up, but navigating the global headwinds requires sharp strategy. The rupee's recent volatility against the dollar underscores the complexities facing Indian businesses, impacting everything from import-export trade to domestic inflation. This week alone, we've seen significant shifts in the IT sector, with major players announcing restructuring and a renewed focus on AI-driven solutions. Meanwhile, the burgeoning startup ecosystem continues to attract substantial funding, despite a cautious global investor sentiment. The government's recent policy announcements on infrastructure development and digitalization are poised to further shape the business landscape, creating both opportunities and challenges for entrepreneurs and established corporations alike. Understanding these market dynamics is crucial for success in today's rapidly evolving Indian economy. Stay informed with Abtak.com for the latest insights and analysis on key sectors including finance, manufacturing, and technology – empowering your business decisions in a dynamic market. Explore the complete business news section now to stay ahead of the curve.
New Delhi, Jun 30 (PTI) Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Healthcare Corporation, it added. Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of ovarian Cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma, the company said. Citing IQVIA data, Alembic said Doxorubicin Hydrochloride Liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2mg/mL) single-dose vials have an estimated market size of USD 29 million for the 12 months ended March 2025. PTI RKL DRR
New Delhi, Sep 16 (PTI) Veteran actor and politician Nafisa Ali Sodhi on Tuesday shared a new update in her cancer battle, saying that she is resuming chemotherapy after undergoing a PET scan. Sodhi has been battling stage-three peritoneal and ovarian cancer since 2018. After the scan, doctors have ruled out surgery as an option. Sodhi shared a quote in her Instagram post which read, "'Who will we turn to when you're gone?' I told them, 'Turn to each other. That is my greatest gift- siblings who share the same love and memories. Protect one another, and remember: your bond is stronger than a ...Read More >
Ahmedabad: Zydus Lifesciences has expanded its presence in the U.S. generics market with a key regulatory approval for a widely used diabetes treatment. Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Dapagliflozin Tablets in 5 mg and 10 mg strengths. This approval enables the company to enter the U.S. market with a generic version of the drug, broadening its portfolio in a high-demand therapeutic category. With the approval, Zydus becomes eligible for 180 days of shared generic drug exclusivity for Dapagliflozin Tablets. This li ...Read More >
New Delhi: Veteran actor and filmmaker Anupam Kher had a proud moment at the premiere of his directorial 'Tanvi The Great', but it was the rare red carpet appearance of his wife, Kirron Kher, that truly tugged at heartstrings. Kirron, dressed in a classic red embroidered salwar suit paired with bold silver jewellery and a matching handbag, walked in holding her husband's hand, her first major public outing in a while. Joining them was their son, Sikander Kher, completing the family picture. The trio appeared at the film's premiere on Thursday evening in Mumbai, and videos of the moment have ...Read More >
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood cancer, lymphoma, Gaucher disease, Pompe disease and haemophilia significantly cheaper and help more patients to avail of treatment, health experts said. A pack of leukaemia drug asciminib 60 (40 mg tablets), which used to cost ₹2,35,000 with GST, will become cheaper by ₹25,000, as per data from market research firm PharmaTrac. Obinutuzu ...Read More >
A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence afte ...Read More >
New Delhi, Dec 18 (PTI) Reliance Nippon Life Insurance, a subsidiary of debt-ridden Reliance Capital (RCAP), has initiated talks with IndusInd Bank for bancassurance partnership as the IIHL and RCAP deal has reached the final lap. Mauritius-based IndusInd International Holdings Ltd (IIHL), the parent entity of IndusInd Bank, won the bid to acquire RCAP and entities under it. Also Read | Cancer Vaccine Ready for Use, Announces Russia; What Is the Cost? How Effective Is It? When Will It Be Available?. "IIHL and Japan-based Nippon Life have struck a good understanding and they are absolutely c ...Read More >
New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to commmercialise its underdevelopment drug aimed to treat cancer and autoimmune diseases in an up to USD 2 billion deal, one of the largest transactions in the pharma sector. The stock surged 9.99 per cent to hit its 52-week high as well as the upper circuit limit of Rs 2,095.65 on the BSE. At the NSE, the stock zoomed 10 per cent to Rs 2,094.40 -- its 52-week high as well as upper circuit level. Glenmark Pharmaceuticals' arm Ichnos Glenmark Innov ...Read More >
Kerala Lottery Result SAMRUDHI SM 12 Results Live: The first winner of today's lottery game- SAMRUDHI SM 12 lottery- takes home Rs 1 crore as a cash prize. The Kerala lottery is one of the most trusted games in the country. Kerala Lottery Result Sunday 20-07-2025: The Kerala lottery is back with another fun game- that may lead you to win Rs 1 crore! The results for today's Kerala lottery games- SAMRUDHI SM 12 Sunday- are announced. The Kerala lottery results are announced here, so people with tickets for today's game can stay in touch with this live blog. Samrudhi Lottery Series: MN, MO, MP, ...Read More >
New Delhi, Dec 17 (PTI) Drug firm Granules India on Tuesday said its subsidiary has received approval from the US health regulator for a generic medication used to treat attention-deficit hyperactivity disorder. Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lisdexamfetamine Dimesylate chewable tablets, the drug firm said in a statement. The approved drug is available in multiple strengths; 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, it added. The company's product is the generic ...Read More >
Mumbai, July 3 (SocialNews.XYZ) Maharashtra Chief Minister Devendra Fadnavis on Thursday said that hydro ganja is proving to be a big challenge for the government, and since it has been legalised in Thailand and America, cases of it being sent via parcel are increasing. He told the state council that the state has written to reduce the commercial quantity of drugs in the rules, which can lead to longer jail terms for the peddlers. "Hydro ganja is proving to be a challenge. Thailand and the US have made it legal. So, hydro ganja is being pushed into the country through courier services and ot ...Read More >
European stocks rose on Friday, heading for small weekly gains, as investors focused on corporate earnings to assess the impact of US tariffs on businesses. The STOXX 600 index climbed 0.3% to 548.84 points, set for its second weekly gain. Other major indexes, including Germany's DAX, France's CAC40, and Britain's FTSE 100, also saw modest increases. Swedish defense company Saab jumped 12.7%, leading the STOXX 600, after reporting better-than-expected second-quarter earnings and raising its sal ...Read More >
Jhargram, Jul 18 (PTI) Three elephants, including two calves, were run over by an express train near Banstala railway station in West Bengal's Paschim Midnapore district, police said on Friday. The incident, which took place on Thursday night, occurred when an elephant herd that probably came from Jharkhand's Dalma forest was traversing, they said. The three pachyderms were mowed on the tracks by a speeding Janshatabdi Express on the Kharagpur-Tatanagar section, a police officer said. It was difficult to go near the carcasses for some time, as the herd of 30 elephants was passing through th ...Read More >
Nizamabad (Telangana) [India], June 29 (ANI): The Government has set a target to export turmeric worth USD 1 billion by the year 2030, Union Home and Cooperation Minister Amit Shah said on Sunday after inaugurating the headquarters of the National Turmeric Board in Telangana's Nizamabad. The inauguration was done almost 21 months after Prime Minister Narendra Modi announced the formation of a turmeric-focused board. There were long-pending demands from farmers for a turmeric board. "During the 2023 Telangana elections in 2023, PM Modi had announced the formation of Turmeric Board... With the ...Read More >
Bengaluru: Alembic Pharmaceuticals, Inc., the U.S. subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. ("Utility") in a $12 million deal to strengthen its presence in the U.S. market. Alembic will begin the commercialization of Utility's recently FDA approved product Pivya® (pivmethecillam) for the treatment of uncomplicated urinary tract infections. Pivya® was approved by the FDA in April 2024. Commenting on the acquisition, Mr. Pranav Amin, Managing Director of Alembic Pharmaceuticals Limited, said: "This acquisition gives us a strategic entry into the special ...Read More >
Ahmedabad -- Senores Pharmaceuticals Limited today announced that it has entered into a definitive agreement to acquire 100% equity stake in Apnar Pharma Private Limited ("Apnar Pharma"), along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets. Apnar Pharma, incorporated on December 12, 2014, is a privately held pharmaceutical company engaged in the licensing, development, and manufacturing of generic formulations for regulated markets including the United States, the Unit ...Read More >
New Delhi, Oct 23 (PTI) Under a fifth of women in low and middle-income countries having breast or cervical cancer are diagnosed at an early stage, compared to two in every five in high-income countries, according to a study published in The Lancet journal, highlighting disparities in cancer care around the world. Too many women, especially in low and middle-income countries, are only diagnosed when their cancer is already advanced, reducing their chances of survival compared to women in wealthier nations. The 'VENUSCANCER' study, led by researchers forming the 'Cancer Survival Group' at the ...Read More >
Amit Shah announced a USD one billion turmeric export target by 2030. He inaugurated the National Turmeric Board headquarters in Nizamabad. The board will focus on farmer prices, exports, and research. Narendra Modi promised the board during the Telangana elections. The government allocated Rs 200 crores to improve turmeric quality and farmer income.Union Home Minister Amit Shah on Sunday said the Centre has set a target of achieving USD one billion in turmeric exports by 2030. Addressing a gath ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Padukone reshared a video of cricketer Jemimah Rodrigues, in which the athlete opened up about her struggl ...Read More >
SRINAGAR, July 11: Director General of Police (DGP), J&K, Nalin Prabhat today chaired a high-level security review meeting in South Kashmir to assess the arrangements for the ongoing Shri Amarnathji Yatra. The meeting was attended by DIG South Kashmir Range Javed Mattoo, SSPs of South Kashmir districts, and senior officers from the Indian Army, CRPF and BSF. Addressing the meeting, the DGP lauded the dedication of all security forces in ensuring the safe conduct of the Yatra. He stressed the importance of regular contingency drills, identifying and addressing security gaps, and updating res ...Read More >
The programme will ensure a 40% increase in patients whose hypertension is controlled and 60% increase in cervical and breast cancer screening for women to accelerate efforts to end preventable deaths The World Bank on Friday (October 24, 2025) said it has approved a $280-million (over 2,450 crore) loan for a health system programme in Kerala to improve the life expectancy and quality of life of 11 million elderly and vulnerable people. The programme aims at treating and supporting over 90% of ...Read More >
AstraZeneca, Pfizer, and Eli Lilly, major players in the pharmaceutical and vaccine sectors, are drawing renewed attention as investors consider the shifting political landscape. AstraZeneca's cancer treatments, including Imfinzi and Calquence, are driving strong revenue growth, while the company plans to launch up to 24 new products by 2030. Eli Lilly, bolstered by its diabetes treatments like Mounjaro and Zepbound, has seen impressive stock gains, despite recent guidance cuts. Pfizer, although facing volatility, is a solid value investment with strong long-term potential. These companies' ro ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Also Read | Bodoland Lottery Result Today, July 10, 2025: Assam State Lottery Sambad Thursday Lucky Draw Results Declared ...Read More >
New Delhi, Apr 9 (PTI) Glenmark Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments. The approval by the US Food and Drug Administration (USFDA) is for progesterone vaginal inserts of strength 100 mg, Glenmark Pharmaceuticals Ltd said in a regulatory filing. It has been determined by the USFDA to be bioequivalent and therapeutically equivalent to the reference listed drug, Endometrin vaginal inserts, 100 mg of Ferring Pharmaceuticals Inc, it added. Glenmark's progest ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Under the agreement, IGI grants AbbVie exclusive rights to globally develop, manufacture, and commercialise ISB 2001 acro ...Read More >
New Delhi: Industry leaders welcomed the recently announced GST reforms, which reduce the number of tax slabs, stating that it will make tax compliance easier while also directly benefiting consumers through lower prices. Jharkhand Chamber of Commerce Joint Secretary Navjot Alang Rubal said that the reduction of the number of slabs from four to two under the new GST structure is a highly positive step. According to Rubal, this reform will greatly benefit the middle and lower-income groups as the tax reductions on essential items of daily use will bring a noticeable drop in prices. He furthe ...Read More >
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactur ...Read More >
New Delhi, Apr 8 (PTI) Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets indicated to control blood sugar in adults with type 2 diabetes mellitus. The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Zydus Lifesciences said in a regulatory filing. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, the company said. Zydus said it is eligible for 180 ...Read More >
New Delhi, Jul 3 (PTI) Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a USD 12 million (over Rs 100 crore) deal to strengthen its presence in the American market. The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement. Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for July 03, 2025 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game. Subsequently, Alembic will begin commercialisation of Utility's recently FDA-approved product Pivya (pivme ...Read More >
New Delhi: What if doctors could tell, right at the time of breast cancer diagnosis, which patient is more likely to face heart problems years later? A new study in JAMA Oncology suggests that may soon be possible.The study, which followed more than 26,000 women with early-stage breast cancer, developed a risk prediction model that can identify those most likely to develop heart failure or cardiomyopathy -- two serious long-term complications of cancer treatment. Researchers found that the model, which factors in age, existing cardiovascular risks and the type of therapy received, could predic ...Read More >
New Delhi [India], October 31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases. In a new draft guidance, the FDA has proposed major updates aimed at simplifying biosimilarity studies and reducing unnecessary clinical testing. The agency also launched a separate initiative to make it easier for biosimilars to be developed as interchangeable with brand-name biologics, allowing patients and pharmacists to ch ...Read More >